Literature DB >> 11600934

Interleukin-6 (IL-6) production by cytokine-stimulated human Müller cells.

S Yoshida1, C Sotozono, T Ikeda, S Kinoshita.   

Abstract

PURPOSE: To investigate whether or not human Müller cells synthesize interleukin (IL)-6.
METHODS: Using RT-PCR, we first confirmed whether cultured human Müller cells express IL-6 mRNA. Then, to determine Müller cell IL-6 production after stimulation, cultured Müller cells were exposed to various concentrations of IL-1beta (0.2 ng/ml, 2 ng/ml, 20 ng/ml) or lipopolysaccharide (LPS) (0.001 microg/ml, 0.1 microg/ml, 10 microg/ml) in 24 hr assays. In addition, to determine Müller cell time-dependent induction of IL-6 production, cultured Müller cells were exposed to IL-1beta (0.02 ng/ml, 2 ng/ml) or LPS (10 microg/ml) for 6, 12, 24, 36 hr. IL-6 production in supernatants was quantified by ELISA:
RESULTS: IL-6 mRNA was expressed in cultured human Müller cells, which produced IL-6 after stimulation with either IL-1beta or LPS for 24 hours. IL-1beta was a significantly more potent stimulator of IL-6 production than was LPS. Exposure of cultured human Müller cells to either IL-1beta or LPS stimulated IL-6 production in a time-dependent fashion.
CONCLUSIONS: Our findings indicate that human Müller cells can produce IL-6 when stimulated by IL-1beta or LPS. Müller cell IL-6 production may have an important role in various conditions involving ocular inflammation

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600934     DOI: 10.1076/ceyr.22.5.341.5498

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  15 in total

Review 1.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

Review 2.  The role of inflammation in diabetic eye disease.

Authors:  Marina Mesquida; Faye Drawnel; Sascha Fauser
Journal:  Semin Immunopathol       Date:  2019-06-07       Impact factor: 9.623

Review 3.  Inflammatory mediators in diabetic retinopathy: Deriving clinicopathological correlations for potential targeted therapy.

Authors:  Abhishek Sheemar; Deepak Soni; Brijesh Takkar; Soumyava Basu; Pradeep Venkatesh
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

Review 4.  Müller cells and diabetic retinopathy.

Authors:  Brandon A Coughlin; Derrick J Feenstra; Susanne Mohr
Journal:  Vision Res       Date:  2017-09-05       Impact factor: 1.886

5.  Interleukin-6 as a photoreceptor neuroprotectant in an experimental model of retinal detachment.

Authors:  Deborah Y Chong; Christopher S Boehlke; Qiong-Duan Zheng; Linda Zhang; Ying Han; David N Zacks
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-31       Impact factor: 4.799

6.  Anti-angiogenic and anti-inflammatory effect of Magnolol in the oxygen-induced retinopathy model.

Authors:  Boyu Yang; Yue Xu; Shanshan Yu; Yongsheng Huang; Lin Lu; Xiaoling Liang
Journal:  Inflamm Res       Date:  2015-11-07       Impact factor: 4.575

7.  Adaptive Müller cell responses to microglial activation mediate neuroprotection and coordinate inflammation in the retina.

Authors:  Minhua Wang; Wenxin Ma; Lian Zhao; Robert N Fariss; Wai T Wong
Journal:  J Neuroinflammation       Date:  2011-12-07       Impact factor: 8.322

8.  Dexamethasone protects retinal ganglion cells but not Müller glia against hyperglycemia in vitro.

Authors:  Xandra Pereiro; Noelia Ruzafa; Arantxa Acera; Alex Fonollosa; F David Rodriguez; Elena Vecino
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

9.  Müller glia as an important source of cytokines and inflammatory factors present in the gliotic retina during proliferative vitreoretinopathy.

Authors:  K Eastlake; P J Banerjee; A Angbohang; D G Charteris; P T Khaw; G A Limb
Journal:  Glia       Date:  2015-11-10       Impact factor: 7.452

Review 10.  Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead.

Authors:  Raquel Boia; Noelia Ruzafa; Inês Dinis Aires; Xandra Pereiro; António Francisco Ambrósio; Elena Vecino; Ana Raquel Santiago
Journal:  Int J Mol Sci       Date:  2020-03-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.